The Journal of Immunology, Vol 151, Issue 4 2024-2031, Copyright © 1993 by American Association of Immunologists

ARTICLES

Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells

TJ Curiel, EC Krug, MB Purner, P Poignard and RL Berens
Infectious Disease Division, University of Colorado Health Sciences Center, Denver 80262.

Infection with Toxoplasma gondii is an important cause of morbidity and mortality throughout the world. In immunocompetent hosts, the infection is usually not significant. However, infection occurring in neonates or other individuals with defective cellular immunity (such as recipients of organ allografts or persons with AIDS) may be life threatening. An effective vaccine to prevent toxoplasmosis, or immunotherapy for persons already infected with Tg would be important additions to the therapeutic armamentarium. We cloned toxoplasma-specific CTL from the PBMC of an asymptomatic individual with serologic evidence for prior Tg infection by stimulation with Ag produced from the RH strain of Tg. These CTL were exclusively of the CD3+, CD4+, CD8- surface phenotype, and lysed autologous target cells that had been either pulsed with Toxoplasma Ag, or infected with live tachyzoites. Lysis of target cells was inhibited by incubation of CTL with anti-T cell antibody, or by incubation of target cells with anti-DR antibody or chloroquine. These CTL also lysed target cells either pulsed with Ag derived from C strain Tg or infected with live C strain tachyzoites, indicating cross- reactivity of recognition. Unlike recently reported murine or human CD8+ Tg-specific CTL, which lysed tachyzoites in an extracellular, and hence HLA-unrestricted environment, these CD4+ CTL had no effect on the infectivity of extracellular tachyzoites. CD8+ Tg-specific CTL were not derived from this donor despite several different approaches to their generation. These data confirm previous reports of human Tg-specific CTL, and extend these observations to include CD4+ CTL. These findings suggest that specific immunotherapy directed against Tg, as well as the development of a preventive vaccine, may be possible.

This article has been cited by other articles:

				S. Wei, B. J. Daniel, M. J. Brumlik, M. E. Burow, W. Zou, I. A. Khan, S. Wadsworth, J. Siekierka, and T. J. Curiel Drugs Designed To Inhibit Human p38 Mitogen-Activated Protein Kinase Activation Treat Toxoplasma gondii and Encephalitozoon cuniculi Infection Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4324 - 4328. [Abstract] [Full Text] [PDF]

				L. M. Staska, C. J. Davies, W. C. Brown, T. C. McGuire, C. E. Suarez, J. Y. Park, B. A. Mathison, J. R. Abbott, and T. V. Baszler Identification of Vaccine Candidate Peptides in the NcSRS2 Surface Protein of Neospora caninum by Using CD4+ Cytotoxic T Lymphocytes and Gamma Interferon-Secreting T Lymphocytes of Infected Holstein Cattle Infect. Immun., March 1, 2005; 73(3): 1321 - 1329. [Abstract] [Full Text] [PDF]

				L. C. Gavrilescu and E. Y. Denkers Apoptosis and the Balance of Homeostatic and Pathologic Responses to Protozoan Infection Infect. Immun., November 1, 2003; 71(11): 6109 - 6115. [Full Text] [PDF]

				L. M. Staska, T. C. McGuire, C. J. Davies, H. A. Lewin, and T. V. Baszler Neospora caninum-Infected Cattle Develop Parasite-Specific CD4+ Cytotoxic T Lymphocytes Infect. Immun., June 1, 2003; 71(6): 3272 - 3279. [Abstract] [Full Text] [PDF]

				T. Scorza, S. D'Souza, M. Laloup, J. Dewit, J. De Braekeleer, H. Verschueren, M. Vercammen, K. Huygen, and E. Jongert A GRA1 DNA Vaccine Primes Cytolytic CD8+ T Cells To Control Acute Toxoplasma gondii Infection Infect. Immun., January 1, 2003; 71(1): 309 - 316. [Abstract] [Full Text] [PDF]

				J. J. Johnson, C. W. Roberts, C. Pope, F. Roberts, M. J. Kirisits, R. Estes, E. Mui, T. Krieger, C. R. Brown, J. Forman, et al. In Vitro Correlates of Ld-Restricted Resistance to Toxoplasmic Encephalitis and Their Critical Dependence on Parasite Strain J. Immunol., July 15, 2002; 169(2): 966 - 973. [Abstract] [Full Text] [PDF]

				S. Wei, F. Marches, J. Borvak, W. Zou, J. Channon, M. White, J. Radke, M.-F. Cesbron-Delauw, and T. J. Curiel Toxoplasma gondii-Infected Human Myeloid Dendritic Cells Induce T-Lymphocyte Dysfunction and Contact-Dependent Apoptosis Infect. Immun., April 1, 2002; 70(4): 1750 - 1760. [Abstract] [Full Text] [PDF]

				E. J. Feron, V. N. A. Klaren, E. A. Wierenga, G. M. G. M. Verjans, and A. Kijlstra Characterization of Toxoplasma gondii-Specific T Cells Recovered from Vitreous Fluid of Patients with Ocular Toxoplasmosis Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3228 - 3232. [Abstract] [Full Text] [PDF]

				W. Zou, J. Borvak, F. Marches, S. Wei, P. Galanaud, D. Emilie, and T. J. Curiel Macrophage-Derived Dendritic Cells Have Strong Th1-Polarizing Potential Mediated by {beta}-Chemokines Rather Than IL-12 J. Immunol., October 15, 2000; 165(8): 4388 - 4396. [Abstract] [Full Text] [PDF]

				I. Prigione, P. Facchetti, L. Lecordier, D. Deslee, S. Chiesa, M.-F. Cesbron-Delauw, and V. Pistoia T Cell Clones Raised from Chronically Infected Healthy Humans by Stimulation with Toxoplasma gondii Excretory-Secretory Antigens Cross-React with Live Tachyzoites: Characterization of the Fine Antigenic Specificity of the Clones and Implications for Vaccine Development J. Immunol., April 1, 2000; 164(7): 3741 - 3748. [Abstract] [Full Text] [PDF]

				E. Y. Denkers and R. T. Gazzinelli Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection Clin. Microbiol. Rev., October 1, 1998; 11(4): 569 - 588. [Abstract] [Full Text] [PDF]

				P. B. Nash, M. B. Purner, R. P. Leon, P. Clarke, R. C. Duke, and T. J. Curiel Toxoplasma gondii-Infected Cells Are Resistant to Multiple Inducers of Apoptosis J. Immunol., February 15, 1998; 160(4): 1824 - 1830. [Abstract] [Full Text] [PDF]

				C.-C. Liu, L. H.Y. Young, and J. D.-E Young Lymphocyte-Mediated Cytolysis and Disease N. Engl. J. Med., November 28, 1996; 335(22): 1651 - 1659. [Full Text] [PDF]